The Role of Cytochrome P-450 mediated metabolites of arachidonic acid in diabetic cardiovascular dysfunction in rats -

dc.contributor.authorZeinab, Nadine Ziad
dc.contributor.departmentDepartment of Pharmacology and Toxicology
dc.contributor.facultyFaculty of Medicine
dc.contributor.institutionAmerican University of Beirut
dc.date2013
dc.date.accessioned2015-02-03T09:54:37Z
dc.date.available2015-02-03T09:54:37Z
dc.date.issued2013
dc.date.submitted2013
dc.descriptionAdvisor : Dr. Ramzi Sabra, Professor, Department of Pharmacology and Toxicology ; Co-Advisor : Dr. Assaad Eid, Assistant Professor ; Committee Members : Dr. Joseph Simaan, Professor, Dr. Nathalie Khoueiry-Zgheib, Associate Professor, Department of Pharmacology and Toxicology.
dc.descriptionThesis (M.Sc.)-- American University of Beirut. Department of Pharmacology and Toxicology. Faculty of Medicine, 2013. W 4
dc.descriptionIncludes bibliographical references (leaves 71-79)
dc.description.abstractBackground: Cardiovascular complications of diabetes mellitus are major causes of the increased mortality and morbidity associated with the disease. Among the manifestations of cardiovascular dysfunction are impaired endothelial mediated vasodilation and vascular responses to vasoactive agents as well as cardiac remodeling with fibrotic changes. Oxidative stress is a major contributor to diabetes induced cardiovascular dysfunction. Recent studies demonstrated significant cardiovascular effects for cytochrome P-450 (CYP-450) mediated arachidonic acid (AA) metabolites, 20-HETE (20- hydroxyeicosatetraenoic acid ) a potent vasoconstrictor, and EET (epoxyeicosatrienoic acid) a vasodilator and potentially cardioprotective eicosanoid. The role of these products in diabetes induced cardiovascular dysfunction, however, is still controversial.Aims: The following study aimed to investigate if blocking 20-HETE production through the treatment with 10 mg-kg-day HET0016 (N-hydroxy-N_-(4-butyl-2 methylphenyl) formamidine), a selective CYP4A isoforms inhibitor, or inducing EETs synthesis by 35 mg-kg-day BNF (β- naphthoflavone), a selective CYP2C11 inducer, in vivo, may decrease diabetes induced cardiovascular dysfunction. CYP-450 has been considered an important source of ROS (reactive oxygen species), so we further investigated the effect of HET0016 and BNF treatment on oxidative stress in diabetes. Our hypothesis was that 20-HETE played a detrimental role while EET’s protected against diabetes induced cardiovascular complications.Methods: Male Sprague- Dawley were divided into four study groups. A dose of 65 mg-kg body weight of streptozotocin (STZ) was used to induce diabetes in three groups. Control (CV) rats were administered the vehicle of STZ (normal saline solution). Two days after STZ, control and diabetic rats (DV) started receiving daily i.p. injections of 5percent DMSO in normal saline, while the remaining two groups received daily i.p. injections of either HET0016 (DH group) or BNF (DF group), dissolved in
dc.format.extentxiv, 79 leaves : illustrations ; 30 cm
dc.identifier.otherb17903567
dc.identifier.urihttp://hdl.handle.net/10938/9943
dc.language.isoen
dc.relation.ispartofTheses, Dissertations, and Projects
dc.subject.classificationW 4 Z46r 2013
dc.subject.lcshDissertations, Academic.
dc.subject.lcshDiabetes Mellitus.
dc.subject.lcshCardiovascular Diseases.
dc.subject.lcshCytochrome P-450 Enzyme System.
dc.subject.lcshArachidonic Acids.
dc.subject.lcshRATS.
dc.titleThe Role of Cytochrome P-450 mediated metabolites of arachidonic acid in diabetic cardiovascular dysfunction in rats -
dc.typeThesis

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
b17903567.pdf
Size:
1.84 MB
Format:
Adobe Portable Document Format